B-12
- Generic Name
- B-12
Management of Preoperative Anaemia in Surgical Oncology
Phase 4
- Conditions
- AnemiaTumor
- Interventions
- First Posted Date
- 2022-08-17
- Last Posted Date
- 2022-08-19
- Target Recruit Count
- 500
- Registration Number
- NCT05505006
- Locations
- 🇮🇹
Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy
Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLC
Phase 3
Completed
- Conditions
- Carcinoma, Non-Small-Cell Lung
- Interventions
- First Posted Date
- 2008-12-11
- Last Posted Date
- 2017-02-02
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 718
- Registration Number
- NCT00806819
- Locations
- 🇺🇦
Boehringer Ingelheim Investigational Site, Vinnytsia, Ukraine
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath